Introduction
Rationing of health care resources is a fact of life; in every country, choices of how best to use resources for health must be made.' The severe resource limitations in developing countries make it even more important than in technically advanced countries to ensure that resource allocation choices lead to the most health for the money.2 In recent years, approaches have been developed that are designed to measure health status by use of composite indicators incorporating morbidity and mortality into one number.'4 These indicators have not yet been forged, however, into practical tools that decision makers can readily use to assist them in making better choices for health spending. This paper presents the first steps toward development of such a tool.
The principal reason for attempting to capture the complex mix of incommensurate consequences resulting from disease into a single number is the need to weigh the benefits of health interventions against their costs. Costs of health programs are expressed in a unidimensional measure, namely dollars; therefore, the benefits to be achieved from their expenditure must also be so expressed.
The purposes of this paper are to modify and further explicate the original formulation of healthy life lost or gained developed by the Ghana Health Assessment team7 and to reformat the original data as a template for a spreadsheet tool for use in resource allocation decisions. We believe that the formulation described in this paper is simpler and more flexible, transparent, and understandable than disability-adjusted life-years (DALY) 1"6 and that it can be used quite directly to assist decision makers. We also compare the reformulated healthy life-years (HeaLYs) from the Ghana data with the DALYs for sub-Saharan Africa presented in the World Development Report. ' Methods and Conceptual Basis for the Healthy Life-Year
The 2 effects of diseases in a population are morbidity and mortality; other consequences are directly related to these effects. These consequences include pain, suffering, fear, and dread; loss of working time and income; worry, anxiety, and breakup of families; disruptions in the life and welfare of the community; and costs of care, coping, and prevention. The HeaLY is a composite measure that combines the amount of healthy life lost due to morbidity with that attributable to premature mortality. It can be applied to individuals or to population groups to determine the impact of a particular disease, to work out the effects of an intervention, or to compare areas, populations, or socioeconomic groups.
This approach uses the pathogenesis and natural history of disease8 as the conceptual framework for assessing morbidity and mortality and for interpreting the effects of various interventions. 
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The onset of disease usually will be dated from the start of symptoms or signs as determined by the individual afflicted, a family member, or a medical practitioner, or as the result of a laboratory test. Termination of a disease state may be by recovery, by death, or by progression to another disease. There are several different patterns of disease evolution; Figure 1 illustrates healthy life lost from disability and from premature death due to typical cases of cirrhosis, polio, and multiple sclerosis in terms of onset, extent, and duration of disability and termination.
Information needs, definition of variables, and formulas to calculate HeaLYs are given in Table 1 . For most diseases, the natural history is determined at onset; therefore, the amount of healthy life lost due to premature mortality should be based on the expectation of life at onset rather than the expectation of life at death. Expectation Figure 2 , which compares loss of discounted DALYs and HeaLYs according to age at death.
Discussion
The HeaLY formulation is based on the original Ghana construct,7"3 but important changes have been introduced. The expectation of life is based on a normative concept of the healthy life that a person should achieve with present knowledge and access to modem health care, as captured in the West model 26 life table9 rather than that based on Ghana's life table. Disability parameters have been standardized for both the severity and duration components to make them more consistent. Discounting at 3% per year is added and affects life expectancy and duration of disability. HeaLYs are expressed in years rather than days. Although we have used the same information as in the original Ghana work, we recognize that estimates for recent years for several diseases would need to be changed. The considerable improvements in health services and extension of coverage have also altered the burden of disease.
There are several differences in this approach from the DALY version formulated in the Global Burden of Disease Study."'7"8 Discounting is done separately rather than being integrated into the formula. No differential is given to the value of life according to the age at which life is lived. Figure 2 shows Figure 2 . This phenomenon was also recently pointed out by Barendregt et al. '9 In the HeaLY formulation, healthy life lost is based on all diseases with onset in a given year and on the stream of life lost due to disability and death thereafter in accordance with the natural history of disease. In the DALY formulation, disability is calculated in an equivalent fashion but termed "life lived with disability," whereas mortality is considered for all deaths in the current year regardless of when onset occurs Age at Death (years) FIGURE 2-Comparison of discounted HeaLYs and DALYs lost from premature mortality, by age at death.
Public Health Policy Forum flexible for this purpose and for including local data and values. Changes in incidence from preventive measures, or changes in case fatality or disability from treatment procedures and alterations in coverage, can be directly incorporated into the spreadsheet. The spreadsheet described in this paper is the first step toward development of a tool to assist in making better choices in health resource allocation. The further steps under way are to add in the expected effects of specific interventions (or packages of interventions) for each disease and an approach to obtaining the unit costs of the interventions. D
